BR0016707A - Forma de dosagem de droga em camadas acionada por hidrogel - Google Patents
Forma de dosagem de droga em camadas acionada por hidrogelInfo
- Publication number
- BR0016707A BR0016707A BR0016707-0A BR0016707A BR0016707A BR 0016707 A BR0016707 A BR 0016707A BR 0016707 A BR0016707 A BR 0016707A BR 0016707 A BR0016707 A BR 0016707A
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- environment
- sertraline
- water
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
"FORMA DE DOSAGEM DE DROGA EM CAMADAS ACIONADA POR HIDROGEL". Uma forma de dosagem de libertação controlada para a sertralina tem uma parte central que compreende uma composição que contém sertralina e uma composição intumescível com água, em que a composição intumescível com água está em uma região separada dentro da parte central. Um revestimento em redor da referida parte central é permeável à água, insolúvel em água e tem pelo menos uma abertura através dele. Em uma modalidade, a forma de dosagem liberta sertralina no ambiente de utilização com uma velocidade média de 6 a 10% em peso por hora da segunda à décima-segunda hora após introdução em um ambiente de utilização e menos do que cerca de 25% em peso durante as primeiras duas horas e pelo menos 70% em peso após a décima-segunda hora, onde as percentagens correspondem à massa de droga libertada do comprimido dividida pela massa total de droga originalmente presente no comprimido. Em uma outra modalidade, a forma de dosagem liberta menos do que cerca de 25% da sertralina no ambiente de utilização duas hora após a introdução da forma de dosagem no ambiente de utilização e liberta pelo menos 25% em peso da oitava à vigésima-quarta hora.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17210899P | 1999-12-23 | 1999-12-23 | |
PCT/IB2000/001871 WO2001047498A2 (en) | 1999-12-23 | 2000-12-13 | Hydrogel-driven layered drug dosage form comprising sertraline |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0016707A true BR0016707A (pt) | 2002-09-03 |
Family
ID=22626396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0016707-0A BR0016707A (pt) | 1999-12-23 | 2000-12-13 | Forma de dosagem de droga em camadas acionada por hidrogel |
Country Status (15)
Country | Link |
---|---|
US (1) | US6899896B2 (pt) |
EP (1) | EP1239839A2 (pt) |
JP (1) | JP2003518487A (pt) |
AR (1) | AR027066A1 (pt) |
AU (1) | AU1724301A (pt) |
BR (1) | BR0016707A (pt) |
CA (1) | CA2395231C (pt) |
CO (1) | CO5271728A1 (pt) |
GT (1) | GT200000220A (pt) |
MX (1) | MXPA02006335A (pt) |
PA (1) | PA8508901A1 (pt) |
PE (1) | PE20010983A1 (pt) |
TN (1) | TNSN00251A1 (pt) |
UY (1) | UY26493A1 (pt) |
WO (1) | WO2001047498A2 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020015731A1 (en) * | 1999-12-23 | 2002-02-07 | Appel Leah E. | Hydrogel-Driven Drug Dosage Form |
DE60233874D1 (de) | 2001-06-22 | 2009-11-12 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
MXPA03011935A (es) * | 2001-06-22 | 2004-03-26 | Pfizer Prod Inc | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco. |
EP1429746B1 (en) * | 2001-09-28 | 2008-08-13 | McNEIL-PPC, INC. | Dosage forms having an inner core and outer shell |
US20040146559A1 (en) * | 2002-09-28 | 2004-07-29 | Sowden Harry S. | Dosage forms having an inner core and outer shell with different shapes |
CA2474838C (en) | 2002-02-01 | 2009-01-06 | Pfizer Products Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
KR101363679B1 (ko) * | 2002-09-20 | 2014-02-14 | 안드렉스 랩스 엘엘씨 | 약제학적 정제 |
US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US20040081695A1 (en) * | 2002-09-28 | 2004-04-29 | Sowden Harry S | Dosage forms having an inner core and an outer shell |
RU2310647C2 (ru) * | 2002-11-07 | 2007-11-20 | Торрент Фармасьютикалз Лтд | Способ получения полиморфной формы гидрохлорида сертралина |
CA2415154C (en) * | 2002-12-24 | 2009-06-16 | Biovail Laboratories Inc. | Modified release formulations of selective serotonin re-uptake inhibitors |
WO2005011635A2 (en) | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
BRPI0509592A (pt) * | 2004-05-06 | 2007-09-25 | Cydex Inc | formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila |
WO2006072878A1 (en) * | 2005-01-07 | 2006-07-13 | Ranbaxy Laboratories Limited | Oral dosage forms of sertraline having controlled particle size and processes for their preparation |
US20060233882A1 (en) * | 2005-04-15 | 2006-10-19 | Sowden Harry S | Osmotic dosage form |
US20060239956A1 (en) * | 2005-04-26 | 2006-10-26 | Lulu Henson | Preparation and use of hydrogels |
WO2007056205A2 (en) * | 2005-11-04 | 2007-05-18 | Eastman Chemical Company | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
WO2007057762A2 (en) * | 2005-11-16 | 2007-05-24 | Pfizer Limited | Osmotic bi-layer tablet |
CN100563637C (zh) * | 2006-10-13 | 2009-12-02 | 北京红林制药有限公司 | 一种控释给药的药芯组合物和控释制剂及其制备方法 |
ECSP077628A (es) | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
RU2016104396A (ru) * | 2009-12-04 | 2018-11-23 | Суновион Фармасьютикалз Инк. | Лекарственные формы, соли и полиморфы транснорсертралина и их применения |
WO2011078993A1 (en) | 2009-12-21 | 2011-06-30 | Aptapharma, Inc. | Functionally-coated multilayer tablets |
WO2016020936A2 (en) * | 2014-07-21 | 2016-02-11 | Patel Jayendrakumar Dasharathlal | A novel oral gastroretentive pharmaceutical dosage form |
JP6455293B2 (ja) * | 2015-04-21 | 2019-01-23 | ニプロ株式会社 | セルトラリン及び/又はその薬学上許容しうる塩を含む製剤 |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4536518A (en) | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US5366738A (en) | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US5082668A (en) | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
USRE33994E (en) | 1983-08-16 | 1992-07-14 | Burroughs Wellcome Co. | Pharmaceutical delivery system |
US4968507A (en) | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
US4624847A (en) | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
US4609374A (en) | 1985-04-22 | 1986-09-02 | Alza Corporation | Osmotic device comprising means for governing initial time of agent release therefrom |
GB8518301D0 (en) | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
US4865598A (en) | 1985-08-16 | 1989-09-12 | Alza Corporation | Dispensing system for administering beneficial agent |
GB8521494D0 (en) | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
IT1188212B (it) | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US4755180A (en) | 1986-06-16 | 1988-07-05 | Alza Corporation | Dosage form comprising solubility regulating member |
DE3868077D1 (de) | 1987-01-14 | 1992-03-12 | Ciba Geigy Ag | Therapeutisches system fuer schwerloesliche wirkstoffe. |
US4915954A (en) | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US4946687A (en) | 1987-10-02 | 1990-08-07 | Alza Corporation | Dosage form for treating cardiovascular diseases |
US4971998A (en) | 1987-10-22 | 1990-11-20 | Massachusetts Institute Of Technology | Methods for treating the premenstrual or late luteal phase syndrome |
US4837111A (en) | 1988-03-21 | 1989-06-06 | Alza Corporation | Dosage form for dispensing drug for human therapy |
FI101344B1 (fi) | 1988-03-31 | 1998-06-15 | Tanabe Seiyaku Co | Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta |
US5030456A (en) | 1988-11-07 | 1991-07-09 | Alza Corporation | Dosage form for treating cardiovascular diseases |
US5034229A (en) | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
IL92966A (en) | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
DD295760A5 (de) | 1989-01-31 | 1991-11-14 | Martin-Luther-Universitaet Halle Wittenberg,De | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
US4981870A (en) | 1989-03-07 | 1991-01-01 | Pfizer Inc. | Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants |
US5019396A (en) | 1989-05-12 | 1991-05-28 | Alza Corporation | Delivery dispenser for treating cardiac arrhythmias |
US5126142A (en) | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore |
US5273752A (en) | 1989-07-18 | 1993-12-28 | Alza Corporation | Controlled release dispenser comprising beneficial agent |
US5130338A (en) | 1989-08-30 | 1992-07-14 | Pfizer Inc. | Method of treating chemical dependencies using sertraline |
US4940731A (en) | 1989-08-30 | 1990-07-10 | Pfizer Inc. | Method of treating premature ejaculation using sertraline |
US5091190A (en) | 1989-09-05 | 1992-02-25 | Alza Corporation | Delivery system for administration blood-glucose lowering drug |
US5035897A (en) | 1989-09-05 | 1991-07-30 | Alza Corporation | Dosage form for delivering soluble or insoluble drugs |
US4962128A (en) | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5200197A (en) | 1989-11-16 | 1993-04-06 | Alza Corporation | Contraceptive pill |
US5178866A (en) | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
US5190763A (en) | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5221536A (en) | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5192550A (en) | 1990-05-07 | 1993-03-09 | Alza Corporation | Dosage form for treating central nervous system disorders |
US5128145A (en) | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
US5057321A (en) | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
US5156850A (en) | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
DK0550641T3 (da) | 1990-09-28 | 1994-08-22 | Pfizer | Dispenseringsanordning indeholdende et hydrofobt medium |
US5284662A (en) | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
US5208037A (en) | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
US5160744A (en) | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
US5178867A (en) | 1991-08-19 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug in short-time period |
ZA927779B (en) | 1991-10-10 | 1993-07-05 | Alza Corp | Osmotic drug delivery devices with hydrophobic wall materials. |
US5183942A (en) | 1991-11-05 | 1993-02-02 | The Scripps Research Institute | Ten-membered ring enediynediols and enediynediones having DNA cleaving properties |
US5543154A (en) | 1991-12-27 | 1996-08-06 | Merck & Co., Inc. | Controlled release nifedipine delivery device |
US5294770A (en) | 1992-01-14 | 1994-03-15 | Alza Corporation | Laser tablet treatment system with dual access to tablet |
US5246711A (en) | 1992-02-27 | 1993-09-21 | Alza Corporation | Dosage form for treating dysthymia |
US5246710A (en) | 1992-02-27 | 1993-09-21 | Alza Corporation | Dosage form for treating cyclothymia |
US5185158A (en) | 1992-02-27 | 1993-02-09 | Alza Corporation | Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same |
US5688518A (en) | 1992-02-27 | 1997-11-18 | Alza Corporation | Antidepressive therapy |
US5609885A (en) | 1992-09-15 | 1997-03-11 | Alza Corporation | Osmotic membrane and delivery device |
US5260069A (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5358721A (en) | 1992-12-04 | 1994-10-25 | Alza Corporation | Antiviral therapy |
DE69425453T2 (de) | 1993-04-23 | 2001-04-12 | Novartis Ag | Wirkstoffabgabevorrichtung mit gesteuerter Freigabe |
US6287598B1 (en) | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
US5455046A (en) | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
HU213407B (en) | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
US5458888A (en) | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
US5458887A (en) | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
ZA953078B (en) | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
ES2163504T5 (es) | 1994-05-06 | 2008-05-16 | Pfizer Inc. | Formas de dosificacion de liberacion controlada de azitromicina. |
US5698224A (en) | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
US5529787A (en) | 1994-07-07 | 1996-06-25 | Alza Corporation | Hydromorphone therapy |
US5718700A (en) | 1994-09-20 | 1998-02-17 | Alza Corporation | Exit means in dosage form |
US5658474A (en) | 1994-12-16 | 1997-08-19 | Alza Corporation | Method and apparatus for forming dispenser delivery ports |
US5607696A (en) | 1995-02-10 | 1997-03-04 | Alza Corporation | Osmotic membrane and delivery device |
US5736159A (en) | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
US5654005A (en) | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
US5837379A (en) | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
CN1158071C (zh) | 1997-05-30 | 2004-07-21 | 渗透有限公司 | 多层渗透装置 |
AU739261B2 (en) * | 1997-07-01 | 2001-10-11 | Pfizer Inc. | Sertraline salts and sustained-release dosage forms of sertraline |
DE60042352D1 (de) * | 1999-02-10 | 2009-07-23 | Pfizer Prod Inc | Osmotisches System zur Verabreichung von Wirkstoffen, die feste amorphe Dispersionen enthalten |
-
2000
- 2000-12-13 AU AU17243/01A patent/AU1724301A/en not_active Abandoned
- 2000-12-13 EP EP00979866A patent/EP1239839A2/en not_active Withdrawn
- 2000-12-13 MX MXPA02006335A patent/MXPA02006335A/es active IP Right Grant
- 2000-12-13 WO PCT/IB2000/001871 patent/WO2001047498A2/en not_active Application Discontinuation
- 2000-12-13 BR BR0016707-0A patent/BR0016707A/pt not_active IP Right Cessation
- 2000-12-13 CA CA002395231A patent/CA2395231C/en not_active Expired - Fee Related
- 2000-12-13 JP JP2001548093A patent/JP2003518487A/ja not_active Withdrawn
- 2000-12-20 US US09/745,096 patent/US6899896B2/en not_active Expired - Fee Related
- 2000-12-20 UY UY26493A patent/UY26493A1/es not_active Application Discontinuation
- 2000-12-21 CO CO00097187A patent/CO5271728A1/es not_active Application Discontinuation
- 2000-12-21 AR ARP000106853A patent/AR027066A1/es unknown
- 2000-12-21 PE PE2000001381A patent/PE20010983A1/es not_active Application Discontinuation
- 2000-12-21 GT GT200000220A patent/GT200000220A/es unknown
- 2000-12-22 PA PA20008508901A patent/PA8508901A1/es unknown
- 2000-12-22 TN TNTNSN00251A patent/TNSN00251A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20010044474A1 (en) | 2001-11-22 |
MXPA02006335A (es) | 2002-12-13 |
UY26493A1 (es) | 2001-07-31 |
WO2001047498A2 (en) | 2001-07-05 |
CA2395231C (en) | 2006-08-15 |
CA2395231A1 (en) | 2001-07-05 |
PA8508901A1 (es) | 2003-12-10 |
TNSN00251A1 (fr) | 2002-05-30 |
WO2001047498A3 (en) | 2001-11-15 |
AR027066A1 (es) | 2003-03-12 |
PE20010983A1 (es) | 2001-10-01 |
US6899896B2 (en) | 2005-05-31 |
AU1724301A (en) | 2001-07-09 |
EP1239839A2 (en) | 2002-09-18 |
GT200000220A (es) | 2002-06-14 |
JP2003518487A (ja) | 2003-06-10 |
CO5271728A1 (es) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0016707A (pt) | Forma de dosagem de droga em camadas acionada por hidrogel | |
BR0113067A (pt) | Forma de dosagem de drogas à base de hidrogel | |
BR0016708A (pt) | Forma de dosagem de droga baseada em hidrogel | |
ATE217192T1 (de) | Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen | |
ATE248589T1 (de) | Matrix zur gesteuerten freisetzung von arzneistoffen | |
PT845989E (pt) | Composicao de farmacos para aliviar a dor | |
NZ314442A (en) | Extended release formulation comprising venlafaxine hydrochloride, film coating composition | |
BR0204001A (pt) | Forma de dosagem oral sólida de simeticona | |
BR0015580A (pt) | Composições analgésicas contendo buprenorfina | |
BR0014159A (pt) | Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional | |
BRPI0414876A (pt) | compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos | |
BR0114410A (pt) | Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade | |
HUP0401714A2 (hu) | Propiverin vagy gyógyászatilag elfogadható sóinak nyújtott hatóanyag-eladású, orális adagolási formái | |
BRPI0516718A (pt) | forma de dosagem de ibuprofeno de liberação modificada | |
CA2338780A1 (en) | Preparation capable of releasing medicinal substance at targeted site in intestine | |
DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
FR2752732B1 (fr) | Forme galenique a liberation prolongee de milnacipran | |
HUP0204340A2 (en) | Compositions for delivery of a cortisol antagonist and their use | |
BR0214716A (pt) | Contraceptivos para prevenção de gravidez e diminuição de sintomatologia pré-menstrual | |
BR9909138A (pt) | Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda | |
BRPI0414386A (pt) | composto, métodos para fabricação do mesmo, para tratamento ou prevenção de uma doença, para ativação da função de er em uma célula óssea, para inibição de função de er em uma célula, para inibição da expressão de il-6, para inibição do crescimento de uma célula neoplásica expressando er, para prevenção de espermatogenese, para prevenção de um efeito reprodutivo adverso associados com exposição a uma falta de equilìbrio hormonal natural ou quìmica ambiental, e, composição | |
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
BR0113148A (pt) | Composições de 2-piridinamina e métodos relacionados | |
BR0308229A (pt) | Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio | |
BR9811424A (pt) | Composição de cuidado oral efervescente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |